Published in BMJ on June 10, 1989
Nephrotoxicity after ifosfamide. Arch Dis Child (1990) 1.10
Childhood cancer: cure at what cost? Arch Dis Child (1990) 1.02
The influence of age on nephrotoxicity following chemotherapy in children. Br J Cancer Suppl (1992) 0.86
Progressive renal toxicity due to ifosfamide. Arch Dis Child (1991) 0.85
Interleukin 18 as a marker of chronic nephropathy in children after anticancer treatment. Dis Markers (2013) 0.81
Dosing and side-effects of ifosfamide plus mesna. J Cancer Res Clin Oncol (1991) 0.77
Hypophosphatemic rickets after ifosfamide treatment. BMJ (1989) 0.75
Renal toxicity and chemotherapy in children with cancer Nephrotoxicity and cancer treatment. Br J Clin Pharmacol (2017) 0.75
Unexpected toxicity in patients treated with iphosphamide. Cancer Res (1972) 1.44
A phase II study of ifosfamide in children with recurrent solid tumours. Cancer Chemother Pharmacol (1985) 1.24
Failure of 2-mercaptoethane sulphonate sodium (mesna) to protect against ifosfamide nephrotoxicity. Eur J Cancer Clin Oncol (1984) 1.11
Renal dysfunction after treatment with isophosphamide (NSC-109724). Cancer Chemother Rep (1974) 1.02
Influence of Visible and Near Infrared Radiant Energy on Organ Development and Pigment Synthesis in Bean and Corn. Plant Physiol (1953) 8.09
Filters for the Isolation of Narrow Regions in the Visible and Near-Visible Spectrum. Plant Physiol (1953) 7.61
Child-resistant packaging and accidental child poisoning. Lancet (1977) 5.63
A Darkroom Safelight for Research in Plant Physiology. Plant Physiol (1957) 4.49
Bicycle injuries in children. Br Med J (1973) 4.44
Stillbirths among offspring of male radiation workers at Sellafield nuclear reprocessing plant. Lancet (1999) 4.18
Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol (2000) 4.15
Water-borne outbreak of campylobacter gastroenteritis. Lancet (1983) 3.97
Investigation of a Campylobacter jejuni outbreak by serotyping and chromosomal restriction endonuclease analysis. J Clin Microbiol (1984) 3.54
Polyacrylamide gel electrophoresis of spiral bacteria from the gastric antrum. Lancet (1984) 3.52
Cytochromes c1 and b2 are sorted to the intermembrane space of yeast mitochondria by a stop-transfer mechanism. Cell (1992) 3.42
SecA protein hydrolyzes ATP and is an essential component of the protein translocation ATPase of Escherichia coli. EMBO J (1989) 3.33
Head injuries in children. Br Med J (1972) 3.26
Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med (1999) 3.03
Cancer in Cumbria and in the vicinity of the Sellafield nuclear installation, 1963-90. BMJ (1993) 2.94
Antigenic analysis of Campylobacter flagellar protein and other proteins. J Clin Microbiol (1985) 2.92
An essential role for ARF6-regulated membrane traffic in adherens junction turnover and epithelial cell migration. EMBO J (2001) 2.50
The identification of outer membrane proteins and flagella of Campylobacter jejuni. J Gen Microbiol (1984) 2.42
Clinical importance of Campylobacter pyloridis and associated serum IgG and IgA antibody responses in patients undergoing upper gastrointestinal endoscopy. J Clin Pathol (1986) 2.38
Intestinal permeability in children with Crohn's disease and coeliac disease. Br Med J (Clin Res Ed) (1982) 2.36
Investigation of leukaemia clusters by use of a Geographical Analysis Machine. Lancet (1988) 2.36
Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet (1997) 2.33
Response definition criteria for ELISPOT assays revisited. Cancer Immunol Immunother (2010) 2.20
Environmental isolation of heat-tolerant Campylobacter in the Southampton area. Lancet (1978) 2.12
Geographical distribution of preconceptional radiation doses to fathers employed at the Sellafield nuclear installation, West Cumbria. BMJ (1993) 2.05
Covert video surveillance: an important investigative tool or a breach of trust? Arch Dis Child (1999) 2.03
Implications of childhood obesity for adult health: findings from thousand families cohort study. BMJ (2001) 2.02
Role of infection in the death of children with acute lymphoblastic leukaemia. Arch Dis Child (1977) 1.97
Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group. J Clin Oncol (1993) 1.93
Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma. Cancer Res (1997) 1.91
Ototoxicity of cisplatinum in children and adolescents. Br J Cancer (1990) 1.88
The virulence of clinical and environmental isolates of Campylobacter jejuni. J Hyg (Lond) (1985) 1.82
A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup. J Clin Oncol (1992) 1.79
Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastoma. Eur J Cancer (1992) 1.76
Campylobacter-associated diarrhoea in Southampton. Br Med J (1977) 1.75
Development of a database of organ doses for paediatric and young adult CT scans in the United Kingdom. Radiat Prot Dosimetry (2012) 1.71
How to organise the paediatric MRCP (UK) part II clinical examination. Arch Dis Child (1997) 1.66
Bicycle saddles and torsion of the testis. Lancet (1978) 1.65
Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma Screening. Lancet (1991) 1.65
Strain variation in Campylobacter pylori detected by numerical analysis of one-dimensional electrophoretic protein patterns. Antonie Van Leeuwenhoek (1989) 1.64
The 'grey toddler'. Chloramphenicol toxicity. Arch Dis Child (1974) 1.62
Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study. Eur J Cancer (2005) 1.60
p53 germline mutations in Li-Fraumeni syndrome. Lancet (1991) 1.58
HIV risk behaviors associated with the injection process: multiperson use of drug injection equipment and paraphernalia in injection drug user networks. Subst Use Misuse (1998) 1.58
Risk of cardiovascular disease measured by carotid intima-media thickness at age 49-51: lifecourse study. BMJ (2000) 1.57
Demonstration of Epstein-Barr viral DNA in formalin-fixed, paraffin-embedded samples of Hodgkin's disease. J Pathol (1990) 1.56
Risk factors for ifosfamide nephrotoxicity in children. Lancet (1996) 1.56
Neonatal transport: a controlled study of skilled assistance. Mortality and morbidity of neonates less than 1.5 kg birth weight. J Pediatr (1978) 1.55
Ifosfamide nephrotoxicity: limited influence of metabolism and mode of administration during repeated therapy in paediatrics. Eur J Cancer (1996) 1.54
A self-supporting library service in a rural region: a new look at hospital consortia. Bull Med Libr Assoc (1982) 1.54
A model of cooperation between complementary and allopathic medicine in a primary care setting. Br J Gen Pract (1990) 1.54
Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line. Cancer Res (2001) 1.52
Long-term fecal excretion and resistance induced in mice infected with Yersinia enterocolitica. Infect Immun (1978) 1.47
CIKS, a connection to Ikappa B kinase and stress-activated protein kinase. Proc Natl Acad Sci U S A (2000) 1.47
Unnecessary school absence after minor injury: case-control study. BMJ (2001) 1.44
The need for endoscopic biopsy in the diagnosis of upper gastrointestinal graft-versus-host disease. J Pediatr Gastroenterol Nutr (1993) 1.44
Childhood cancer in Cumbria. Lancet (1983) 1.44
Childhood cancer in the Northern Region, 1968-82: incidence in small geographical areas. J Epidemiol Community Health (1985) 1.43
Child-resistant containers really are effective. Lancet (1979) 1.43
Radon and childhood cancers. Eur J Cancer (1996) 1.43
Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma. Med Pediatr Oncol (2003) 1.43
Inpatient cardiopulmonary resuscitation: is survival prediction possible? South Med J (1991) 1.41
Methotrexate-induced malabsorption in children with acute lymphoblastic leukaemia. Br Med J (1977) 1.41
Screening infants for neuroblastoma: the parents' perspective in false-positive cases. Pediatr Hematol Oncol (1994) 1.40
Intracranial calcification in survivors of childhood medulloblastoma. Arch Dis Child (1983) 1.39
Decline in incidence of medulloblastoma in children. Cancer (1994) 1.38
Apparent clusters of childhood lymphoid malignancy in Northern England. Lancet (1984) 1.38
Neonatal vitamin K administration and childhood cancer in the north of England: retrospective case-control study. BMJ (1998) 1.38
A controlled study of virtual reality exposure therapy for the fear of flying. J Consult Clin Psychol (2000) 1.38
A lifecourse study of risk for hyperinsulinaemia, dyslipidaemia and obesity (the central metabolic syndrome) at age 49-51 years. Diabet Med (2003) 1.37
Case of tularaemia in England. Br Med J (1972) 1.37
Performance of serum-supplemented and serum-free media in IFNgamma Elispot Assays for human T cells. Cancer Immunol Immunother (2009) 1.36
Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours. Br J Cancer (1992) 1.36
Circumstances surrounding deaths from accidental poisoning 1974-80. Arch Dis Child (1983) 1.35
Serial studies of numbers of circulating T and B lymphocytes in children with acute lymphoblastic leukaemia. Arch Dis Child (1977) 1.34
Changing pattern of poisoning in children in Newcastle, 1974-81. Br Med J (Clin Res Ed) (1983) 1.33
The extent of surface contamination of retailed chickens with Campylobacter jejuni serogroups. Epidemiol Infect (1988) 1.32
Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group 'Survey' 1982-1992. Eur J Cancer (2000) 1.32
Serum ferritin in juvenile chronic polyarthritis. Ann Rheum Dis (1977) 1.29
Incidence and survival for cancer in children and young adults in the North of England, 1968-1995: a report from the Northern Region Young Persons' Malignant Disease Registry. Br J Cancer (2000) 1.29
Cheese-borne listeria meningitis in immunocompetent patient. Lancet (1989) 1.28
Expression of the Thy-1 glycoprotein gene by DNA-mediated gene transfer. Proc Natl Acad Sci U S A (1984) 1.28
Mutations in U1 snRNA bypass the requirement for a cell type-specific RNA splicing factor. Cell (1993) 1.27
Recognition and management of teething diarrhea among Florida pediatricians. Clin Pediatr (Phila) (1995) 1.26
Increase in severity of graft versus host disease by cytomegalovirus. J Clin Pathol (1992) 1.25
Measles in children who have malignant disease. Br Med J (Clin Res Ed) (1987) 1.23
Intellect after malignancy. Arch Dis Child (1986) 1.22
Comparison of methods for the estimation of carboplatin pharmacokinetics in paediatric cancer patients. Eur J Cancer (1995) 1.20
A pilot validation in 10 European Union Member States of a point prevalence survey of healthcare-associated infections and antimicrobial use in acute hospitals in Europe, 2011. Euro Surveill (2015) 1.19
Accidental childhood poisoning with household products. Br Med J (Clin Res Ed) (1984) 1.18
Relationship between acute morphine and the course of PTSD in children with burns. J Am Acad Child Adolesc Psychiatry (2001) 1.15
Ewing's tumors with primary lung metastases: survival analysis of 114 (European Intergroup) Cooperative Ewing's Sarcoma Studies patients. J Clin Oncol (1998) 1.14
Two families with the Li-Fraumeni cancer family syndrome. J Med Genet (1982) 1.14